{
    "2021-07-02": [
        [
            {
                "time": "",
                "original_text": "BPI-3016是贝达自主研发的天然胰高血糖素样肽-1（GLP-1）类似物，拟用于糖尿病的治疗，目前该项目针对糖尿病适应症的I期临床研究正在进行中",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "BPI-3016",
                        "GLP-1",
                        "糖尿病",
                        "I期临床"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "公司产品埃克替尼、恩沙替尼均属于尚在专利保护期内的1类新药",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "埃克替尼",
                        "恩沙替尼",
                        "专利保护",
                        "1类新药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}